Proteomics of the heart: Unraveling disease

Circulation Research

Volumn 98, Issue 3, 2006, Pages 309-321

  McGregor, Emma ^a   Dunn, Michael J ^b  

^a BioScience Communications   (United Kingdom)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Cardiomyopathy; Heart failure; Mass spectrometry; Proteomics; Two dimensional gel electrophoresis

Indexed keywords

MESSENGER RNA; PROTEIN;

BIOINFORMATICS; CELL LYSATE; DOG; GEL ELECTROPHORESIS; HEART DISEASE; HEART FAILURE; HUMAN; HUMAN CELL; HUMAN TISSUE; MASS SPECTROMETRY; MOLECULAR MODEL; MORBIDITY; MORTALITY; NONHUMAN; PH MEASUREMENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEOMICS; QUANTITATIVE ANALYSIS; RAT; REVIEW;

DEVELOPED COUNTRIES; GENOME, HUMAN; HEART DISEASES; HUMANS; PROTEOME; PROTEOMICS;

EID: 33646814039     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000201280.20709.26     Document Type: Review

References (153)

1. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, et al; International Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome. Nature. 2001;409:860-921.
2. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, Smith HO, Yandell M, Evans CA, Holt RA, et al. The sequence of the human genome. Science. 2001;291:1304-1351.
3. Anderson L, Seilhamer J. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis. 1997;18:533-537.
4. Gygi SP, Rochon Y, Franza BR, Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol Cell Biol. 1999;19:1720-1730.
5. Gooley AA, Packer NH. The importance of protein co- and post-translational modifications in proteome projects. In: Wilkins MR, Williams KL, Appel RD, Hochstrasser DF, eds. Proteome Research: New Frontiers in Functional Genomics. Berlin: Springer; 1997.
6. Clark TA, Sugnet CW, Ares M Jr. Genomewide analysis of mRNA processing in yeast using splicing-specific microarrays. Science. 2002;296:907-910.
7. Anderson NG, Matheson A, Anderson NL. Back to the future: the human protein index (HPI) and the agenda for post-proteomic biology. Proteomics. 2001;1:3-12.
8. Anderson NG, Anderson L. The human protein index. Clin Chem. 1982;28:739-748.
9. Klose J. Protein mapping by combined isoelectric focusing and electrophoresis of mouse tissues. A novel approach to testing for induced point mutations in mammals. Humangenetik. 1975;26:231-243.
10. O'Farrell PH. High resolution two-dimensional electrophoresis of proteins. J Biol Chem. 1975;250:4007-4021.
11. Wasinger VC, Cordwell SJ, Cerpa-Poljak A, Yan JX, Gooley AA, Wilkins MR, Duncan MW, Harris R, Williams KL, Humphery-Smith I. Progress with gene-product mapping of the Mollicutes: Mycoplasma genitalium. Electrophoresis. 1995;16:1090-1094.
12. Wilkins MR, Sanchez JC, Gooley AA, Appel RD, Humphery-Smith I, Hochstrasser DF, Williams KL. Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it. Biotechnol Genet Eng Rev. 1996;13:19-50.
13. Gorg A, Weiss W, Dunn MJ. Current two-dimensional electrophoresis technology for proteomics. Proteomics. 2004;4:3665-3685.
14. Santoni V, Kieffer S, Desclaux D, Masson F, Rabilloud T. Membrane proteomics: use of additive main effects with multiplicative interaction model to classify plasma membrane proteins according to their solubility and electrophoretic properties. Electrophoresis. 2000;21:3329-3344.
15. Luche S, Santoni V, Rabilloud T. Evaluation of nonionic and zwitterionic detergents as membrane protein solubilizers in two-dimensional electrophoresis. Proteomics. 2003;3:249-253.
16. Rabilloud T. Use of thiourea to increase the solubility of membrane proteins in two-dimensional electrophoresis. Electrophoresis. 1998;19:758-760.
17. Herbert BR, Molloy MP, Gooley AA, Walsh BJ, Bryson WG, Williams KL. Improved protein solubility in two-dimensional electrophoresis using tributyl phosphine as reducing agent. Electrophoresis. 1998;19:845-851.
18. Stanley BA, Neverova I, Brown HA, Van Eyk JE. Optimizing protein solubility for two-dimensional gel electrophoresis analysis of human myocardium. Proteomics. 2003;3:815-820.
19. Rabilloud T. Two-dimensional gel electrophoresis in proteomics: old, old fashioned, but it still climbs up the mountains. Proteomics. 2002;2:3-10.
20. Pedersen SK, Harry JL, Sebastian L, Baker J, Traini MD, McCarthy JT, Manoharan A, Wilkins MR, Gooley AA, Righetti PG, Packer NH, Williams KL, Herbert BR. Unseen proteome: mining below the tip of the iceberg to find low abundance and membrane proteins. J Proteome Res. 2003;2:303-311.
21. Gorg A, Obermaier C, Boguth G, Harder A, Scheibe B, Wildgruber R, Weiss W. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis. 2000;21:1037-1053.
22. Patton WF, Schulenberg B, Steinberg TH. Two-dimensional gel electrophoresis; better than a poke in the ICAT? Curr Opin Biotechnol. 2002;13:321-328.
23. Li ZB, Flint PW, Boluyt MO. Evaluation of several two-dimensional gel electrophoresis techniques in cardiac proteomics. Electrophoresis. 2005; 26:3572-3585.
24. Gygi SP, Corthals GL, Zhang Y, Rochon Y, Aebersold R. Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Proc Natl Acad Sci U S A. 2000;97:9390-9395.
25. Westbrook JA, Yan JX, Wait R, Welson SY, Dunn MJ. Zooming-in on the proteome: very narrow-range immobilised pH gradients reveal more protein species and isoforms. Electrophoresis. 2001;22:2865-2871.
26. Wildgruber R, Harder A, Obermaier C, Boguth G, Weiss W, Fey SJ, Larsen PM, Gorg A. Towards higher resolution: two-dimensional electrophoresis of Saccharomyces cerevisiae proteins using overlapping narrow immobilized pH gradients. Electrophoresis. 2000;21:2610-2616.
27. Bae SH, Harris AG, Hains PG, Chen H, Garfin DE, Hazell SL, Paik YK, Walsh BJ, Cordwell SJ. Strategies for the enrichment and identification of basic proteins in proteome projects. Proteomics. 2003;3:569-579.
28. Gorg A, Boguth G, Obermaier C, Posch A, Weiss W. Two-dimensional polyacrylamide gel electrophoresis with immobilized pH gradients in the first dimension (IPG-Dalt): the state of the art and the controversy of vertical versus horizontal systems. Electrophoresis. 1995;16:1079-1086.
29. Hoving S, Gerrits B, Voshol H, Muller D, Roberts RC, van Oostmm J. Preparative two-dimensional gel electrophoresis at alkaline pH using narrow range immobilized pH gradients. Proteomics. 2002;2:127-134.
30. Olsson I, Larsson K, Palmgren R, Bjellqvist B. Organic disulfides as a means to generate streak-free two-dimensional maps with narrow range basic immobilized pH gradient strips as first dimension. Proteomics. 2002;2:1630-1632.
31. Pennington K, McGregor E, Beasley CL, Everall I, Cotter D, Dunn MJ. Optimization of the first dimension for separation by two-dimensional gel electrophoresis of basic proteins from human brain tissue. Proteomics. 2004;4:27-30.
32. Corthals GL, Wasinger VC, Hochstrasser DF, Sanchez JC. The dynamic range of protein expression: a challenge for proteomic research. Electrophoresis. 2000;21:1104-1115.
33. Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics. 2002;1:845-867.
34. Fountoulakis M, Berndt P, Langen H, Suter L. The rat liver mitochondrial proteins. Electrophoresis. 2002;23:311-328.
35. Kernec F, Unlu M, Labeikovsky W, Minden JS, Koretsky AP. Changes in the mitochondrial proteome from mouse hearts deficient in creatine kinase. Physiol Genomics. 2001;6:117-128.
36. Molloy MP, Herbert BR, Walsh BJ, Tyler MI, Traini M, Sanchez JC, Hochstrasser DF, Williams KL, Gooley AA. Extraction of membrane proteins by differential solubilization for separation using two-dimensional gel electrophoresis. Electrophoresis. 1998;19:837-844.
37. Banks RE, Dunn MJ, Forbes MA, Stanley A, Pappin D, Naven T, Gough M, Harnden P, Selby PJ. The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis-preliminary findings. Electrophoresis. 1999;20:689-700.
38. Craven RA, Banks RE. Use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis. Methods Enzymol. 2002;356:33-49.
39. Jain KK. Application of laser capture microdissection to proteomics. Methods Enzymol. 2002;356:157-167.
40. De Souza AI, McGregor E, Dunn MJ, Rose ML. Preparation of human heart for laser microdissection and proteomics. Proteomics. 2004;4:578-586.
41. Hoffmann P, Ji H, Moritz RL, Connolly LM, Frecklington DF, Layton MJ, Eddes JS, Simpson RJ. Continuous free-flow electrophoresis separation of cytosolic proteins from the human colon carcinoma cell line LIM 1215: a non two-dimensional gel electrophoresis-based proteome analysis strategy. Proteomics. 2001;1:807-818.
42. Hesse C, Nilsson CL, Blennow K, Davidsson P. Identification of the apolipoprotein E4 isoform in cerebrospinal fluid with preparative two-dimensional electrophoresis and matrix assisted laser desorption/ionization- time of flight-mass spectrometry. Electrophoresis. 2001;22:1834-1837.
43. Zuo X, Speicher DW. A method for global analysis of complex proteomes using sample prefractionation by solution isoelectrofocusing prior to two-dimensional electrophoresis. Anal Biochem. 2000;284:266-278.
44. Zuo X, Echan L, Hembach P, Tang HY, Speicher KD, Santoli D, Speicher DW. Towards global analysis of mammalian proteomes using sample prefractionation prior to narrow pH range two-dimensional gels and using one-dimensional gels for insoluble and large proteins. Electrophoresis. 2001;22:1603-1615.
45. Figeys D, Pinto D. Proteomics on a chip: promising developments. Electrophoresis. 2001;22:208-216.
46. Wolters DA, Washburn MP, Yates JR III. An automated multidimensional protein identification technology for shotgun proteomics. Anal Chem. 2001;73:5683-5690.
47. Washburn MP, Wolters D, Yates JR, III. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol. 2001;19:242-247.
48. Kislinger T, Gramolini AO, MacLennan DH, Emili A. Multidimensional protein identification technology (MudPIT): technical overview of a profiling method optimized for the comprehensive proteomic investigation of normal and diseased heart tissue. J Am Soc Mass Spectrom. 2005;16:1207-1220.
49. Smith RD, Anderson GA, Lipton MS, Masselon C, Pasa-Tolic L, Shen Y, Udseth HR. The use of accurate mass tags for high-throughput microbial proteomics. OMICS. 2002;6:61-90.
50. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol. 1999;17:994-999.
51. Yi EC, Li XJ, Cooke K, Lee H, Raught B, Page A, Aneliunas V, Hieter P, Goodlett DR, Aebersold R. Increased quantitative proteome coverage with (13)C/(12)C-based, acid-cleavable isotope-coded affinity tag reagent and modified data acquisition scheme. Proteomics. 2005;5:380-387.
52. Flory MR, Griffin TJ, Martin D, Aebersold R. Advances in quantitative proteomics using stable isotope tags. Trends Biotechnol. 2002;20:S23-S29.
53. Ross PL, Huang YN, Marchese JN, Williamson B, Parker K, Hattan S, Khainovski N, Pillai S, Dey S, Daniels S, Purkayastha S, Juhasz P, Martin S, Bartlet-Jones M, He F, Jacobson A, Pappin DJ. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics. 2004;3:1154-1169.
54. Zhang Y, Wolf-Yadlin A, Ross PL, Pappin DJ, Rush J, Lauffenburger DA, White FM. Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules. Mol Cell Proteomics. 2005;4:1240-1250.
55. Julka S, Regnier FE. Recent advancements in differential proteomics based on stable isotope coding. Brief Funct Genomic Proteomic. 2005;4:158-177.
56. Arnott D, Kishiyama A, Luis EA, Ludlum SG, Marsters JC Jr, Stults JT. Selective detection of membrane proteins without antibodies: a mass spectrometric version of the Western blot. Mol Cell Proteomics. 2002;1:148-156.
57. Jenkins RE, Pennington SR. Arrays for protein expression profiling: towards a viable alternative to two-dimensional gel electrophoresis? Proteomics. 2001;1:13-29.
58. Lal SP, Christopherson RI, dos Remedios CG. Antibody arrays: an embryonic but rapidly growing technology. Drug Discov Today. 2002;7:S143-S149.
59. Mitchell P. A perspective on protein microarrays. Nat Biotechnol. 2002;20:225-229.
60. Horn S, Leuking A, Murphy D, Staudt A, Gutjahr C, Schulte K, Konig A, Landsberger M, Lehrach H, Feli SB, Cahill DJ. Profiling humoral auto-immune repertoire of dilated cardiomyopathy (DCM) patients and development of a disease-associated protein chip. Proteomics. In press.
61. Lauber WM, Carroll JA, Dufield DR, Kiesel JR, Radabaugh MR, Malone JP. Mass spectrometry compatibility of two-dimensional gel protein stains. Electrophoresis. 2001;22:906-918.
62. Unlu M, Morgan ME, Minden JS. Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis. 1997;18:2071-2077.
63. Lilley KS, Friedman DB. All about DIGE: quantification technology for differential-display 2D-gel proteomics. Expert Rev Proteomics. 2004;1:401-409.
64. Yan JX, Devenish AT, Wait R, Stone T, Lewis S, Fowler S. Fluorescence two-dimensional difference gel electrophoresis and mass spectrometry based proteomic analysis of Escherichia coli. Proteomics. 2002;2:1682-1698.
65. Alban A, Olu David S, Bjorkesten L, Andersson C, Sloge E, Lewis S, Currie I. A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics. 2003;3:36-44.
66. Shaw J, Rowlinson R, Nickson J, Stone T, Sweet A, Williams K, Tonge R. Evaluation of saturation labeling two-dimensional difference gel electrophoresis fluorescent dyes. Proteomics. 2003;3:1181-1195.
67. Greengauz-Roberts O, Stoppler H, Nomura S, Yamaguchi H, Goldenring JR, Podolsky RH, Lee JR, Dynan WS. Saturation labeling with cysteine-reactive cyanine fluorescent dyes provides increased sensitivity for protein expression profiling of laser-microdissected clinical specimens. Proteomics. 2005;5:1746-1757.
68. Martin K, Steinberg TH, Goodman T, Schulenberg B, Kilgore JA, Gee KR, Beechem JM, Patton WF. Strategies and solid-phase formats for the analysis of protein and peptide phosphorylation employing a novel fluorescent phosphorylation sensor dye. Comb Chem High Throughput Screen. 2003;6:331-339.
69. Steinberg TH, Pretty On Top, Berggren KN, Kemper C, Jones L, Diwu Z, Haugland RP, Patton WF. Rapid and simple single nanogram detection of glycoproteins in polyacrylamide gels and on electroblots. Proteomics. 2001;1:841-855.
70. Patterson SD, Aebersold R. Mass spectrometric approaches for the identification of gel-separated proteins. Electrophoresis. 1995;16:1791-1814.
71. Yates JR III. Mass spectrometry and the age of the proteome. J Mass Spectrom. 1998;33:1-19.
72. Byers HL, Ward MA. Mass spectrometry - a powerful analytical tool. In: Van Eyk JE, Dunn MJ, eds. Proteomic and Genomic Analysis of Cardiovascular Disease. Weinheim: WILEY-VCH GmbH & Co. KGaA; 2003.
73. Wheeler CH, Berry SL, Wilkins MR, Corbett JM, Ou K, Gooley AA, Humphery-Smith I, Williams KL, Dunn MJ. Characterization of proteins from two-dimensional electrophoresis gels by matrix-assisted laser desorption mass spectrometry and amino acid compositional analysis. Electrophoresis. 1996;17:580-587.
74. Mann M, Wilm M. Error-tolerant identification of peptides in sequence databases by peptide sequence tags. Anal Chem. 1994;66:4390-4399.
75. Eng JK. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J Am Soc Mass Spec. 1994;5:976-989.
76. Dowsey AW, Dunn MJ, and Yang GZ. The role of bioinformatics in two-dimensional gel electrophoresis. Proteomics. 2003;3:1567-1596.
77. Noble D. Modeling the heart-from genes to cells to the whole organ. Science. 2002;295:1678-1682.
78. Orchard S, Hermjakob H, Taylor CF, Potthast F, Jones P, Zhu W, Julian RK, Apweiler R. Further steps in standardization: report of the second annual proteomics standards initiative spring workshop (Siena, Italy, April 17-20, 2005). Proteomics. 2005;5:3552-3555.
79. Orchard S, Hermjakob H, Taylor C, Aebersold R, Apweiler R. Human proteome organization proteomics standards initiative: pre-congress workshop. Proteomics. 2005;5:DOI 10.1002/pmic.200500727.
80. Appel RD, Bairoch A, Sanchez JC, Vargas JR, Golaz O, Pasquali C, Hochstrasser DF. Federated two-dimensional electrophoresis database: a simple means of publishing two-dimensional electrophoresis data. Electrophoresis. 1996;17:540-546.
81. Li XP, Pleissner KP, Scheler C, Regitz-Zagrosek V, Salnikow J, Jungblut PR. A two-dimensional electrophoresis database of rat heart proteins. Electrophoresis. 1999;20:891-897.
82. Dunn MJ, Corbett JM, Wheeler CH. HSC-2DPAGE and the two-dimensional gel electrophoresis database of dog heart proteins. Electrophoresis. 1997;18:2795-2802.
83. Evans G, Wheeler CH, Corbett JM, Dunn MJ. Construction of HSC-2DPAGE: a two-dimensional gel electrophoresis database of heart proteins. Electrophoresis. 1997;18:471-479.
84. Muller EC, Thiede B, Zimny-Arndt U, Scheler C, Prehm J, Muller-Werdan U, Wittmann-Liebold B, Otto A, Jungblut P. High-performance human myocardial two-dimensional electrophoresis database: edition 1996. Electrophoresis. 1996;17:1700-1712.
85. Pleissner KP, Sander S, Oswald H, Regitz-Zagrosek V, Fleck E. The construction of the World Wide Web-accessible myocardial two-dimensional gel electrophoresis protein database "HEART-2DPAGE": a practical approach. Electrophoresis. 1996;17:1386-1392.
86. Corbett JM, Why HJ, Wheeler CH, Richardson PJ, Archard LC, Yacoub MH, Dunn MJ. Cardiac protein abnormalities in dilated cardiomyopathy detected by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis. 1998;19:2031-2042.
87. Knecht M, Regitz-Zagrosek V, Pleissner KP, Emig S, Jungblut P, Hildebrandt A, Fleck E. Dilated cardiomyopathy: computer-assisted analysis of endomyocardial biopsy protein patterns by two-dimensional gel electrophoresis. Eur J Clin Chem Clin Biochem. 1994;32:615-624.
88. Knecht M, Regitz-Zagrosek V, Pleissner KP, Jungblut P, Steffen C, Hildebrandt A, Fleck E Characterization of myocardial protein composition in dilated cardiomyopathy by two-dimensional gel electrophoresis. Eur Heart J. 1994;15 Suppl D:37-44.
89. Pleissner KP, Regitz-Zagrosek V, Weise C, Neuss M, Krudewagen B, Soding P, Buchner K, Hucho F, Hildebrandt A, Fleck E. Chamber-specific expression of human myocardial proteins detected by two-dimensional gel electrophoresis. Electrophoresis. 1995;16:841-850.
90. Scheler C, Li XP, Salnikow J, Dunn MJ, Jungblut PR. Comparison of two-dimensional electrophoresis patterns of heat shock protein Hsp27 species in normal and cardiomyopathic hearts. Electrophoresis. 1999;20:3623-3628.
91. Otto A, Thiede B, Muller EC, Scheler C, Wittmann-Liebold B, Jungblut P. Identification of human myocardial proteins separated by two-dimensional electrophoresis using an effective sample preparation for mass spectrometry. Electrophoresis. 1996;17:1643-1650.
92. Pleissner KP, Soding P, Sander S, Oswald H, Neuss M, Regitz-Zagrosek V, Fleck E. Dilated cardiomyopathy-associated proteins and their presentation in a WWW-accessible two-dimensional gel protein database. Electrophoresis. 1997;18:802-808.
93. Thiede B, Otto A, Zimny-Arndt U, Muller EC, Jungblut P. Identification of human myocardial proteins separated by two-dimensional electrophoresis with matrix-assisted laser desorption/ionization mass spectrometry. Electrophoresis. 1996;17:588-599.
94. McGregor E, Dunn MJ. Proteomics of heart disease. Hum Mol Genet. 2003;12 Spec No 2:R135-R144.
95. Fernando P, Deng W, Pekalska B, DeRepentigny Y, Kothary R, Kelly JF, Megeney LA. Active kinase proteome screening reveals novel signal complexity in cardiomyopathy. Mol Cell Proteomics. 2005;4:673-682.
96. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124-1136.
97. Marber M, Walker D, Yellon D. Ischaemic preconditioning. BMJ. 1994;308:1-2.
98. Ytrehus K, Liu Y, Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol. 1994;266:H1145-H1152.
99. Goto M, Liu Y, Yang XM, Ardell JL, Cohen MV, Downey JM. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res. 1995;77:611-621.
100. Kitakaze M, Node K, Minamino T, Komamura K, Funaya H, Shinozaki Y, Chujo M, Mori H, Inoue M, Hori M, Kamada T. Role of activation of protein kinase C in the infarct size-limiting effect of ischemic preconditioning through activation of ecto-5′-nucleotidase. Circulation. 1996;93:781-791.
101. Liu Y, Tsuchida A, Cohen MV, Downey JM. Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts. J Mol Cell Cardiol. 1995;27:883-892.
102. Mitchell MB, Meng X, Ao L, Brown JM, Harken AH, Banerjee A. Preconditioning of isolated rat heart is mediated by protein kinase C. Circ Res. 1995;76:73-81.
103. Gray MO, Karliner JS, Mochly-Rosen D. A selective epsilon-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death. J Biol Chem. 1997;272:30945-30951.
104. Liu GS, Cohen MV, Mochly-Rosen D, Downey JM. Protein kinase C-epsilon is responsible for the protection of preconditioning in rabbit cardiomyocytes. J Mol Cell Cardiol. 1999;31:1937-1948.
105. Saurin AT, Pennington DJ, Raat NJ, Latchman DS, Owen MJ, Marber MS. Targeted disruption of the protein kinase C epsilon gene abolishes the infarct size reduction that follows ischaemic preconditioning of isolated buffer-perfused mouse hearts. Cardiovasc Res. 2002;55:672-680.
106. Vondriska TM, Klein JB, Ping P. Use of functional proteomics to investigate PKC epsilon-mediated cardioprotection: the signaling module hypothesis. Am J Physiol Heart Circ Physiol. 2001;280:H1434-H1441.
107. Baines CP, Zhang J, Wang GW, Zheng YT, Xiu JX, Cardwell EM, Bolli R, Ping P. Mitochondrial PKCepsilon and MAPK form signaling modules in the murine heart: enhanced mitochondrial PKCepsilon-MAPK interactions and differential MAPK activation in PKCepsilon-induced cardioprotection. Circ Res. 2002;90:390-397.
108. Edmondson RD, Vondriska TM, Biederman KJ, Zhang J, Jones RC, Zheng Y, Allen DL, Xiu JX, Cardwell EM, Pisano MR, Ping P. Protein kinase C epsilon signaling complexes include metabolism- and transcription/translation-related proteins: complimentary separation techniques with LC/MS/MS. Mol Cell Proteomics. 2002;1:421-433.
109. Li RC, Ping P, Zhang J, Wead WB, Cao X, Gao J, Zheng Y, Huang S, Han J, Bolli R. PKCepsilon modulates NF-kappaB and AP-1 via mitogen-activated protein kinases in adult rabbit cardiomyocytes. Am J Physiol Heart Circ Physiol. 2000;279:H1679-H1689.
110. Ping P, Zhang J, Pierce WM Jr, Bolli R. Functional proteomic analysis of protein kinase C epsilon signaling complexes in the normal heart and during cardioprotection. Circ Res. 2001;88:59-62.
111. Vondriska TM, Zhang J, Song C, Tang XL, Cao X, Baines CP, Pass JM, Wang S, Bolli R, Ping P. Protein kinase C epsilon-Src modules direct signal transduction in nitric oxide-induced cardioprotection: complex formation as a means for cardioprotective signaling. Circ Res. 2001;88:1306-1313.
112. Zhang J, Baines CP, Zong C, Cardwell EM, Wang G, Vondriska TM, Ping P. Functional proteomic analysis of a three-tier PKCepsilon-Akt-eNOS signaling module in cardiac protection. Am J Physiol Heart Circ Physiol. 2005;288:H954-H961.
113. Hirano M, Davidson M, DiMauro S. Mitochondria and the heart. Curr Opin Cardiol. 2001;16:201-210.
114. Lopez MF, Melov S. Applied proteomics: mitochondrial proteins and effect on function. Circ Res. 2002;90:380-389.
115. Taylor SW, Fahy E, Zhang B, Glenn GM, Warnock DE, Wiley S, Murphy AN, Gaucher SP, Capaldi RA, Gibson BW, Ghosh SS. Characterization of the human heart mitochondrial proteome. Nat Biotechnol. 2003;21:281-286.
116. Fountoulakis M, Schlaeger EJ. The mitochondrial proteins of the neuroblastoma cell line IMR-32. Electrophoresis. 2003;24:260-275.
117. Liu XH, Qian LJ, Gong JB, Shen J, Zhang XM, Qian XH. Proteomic analysis of mitochondrial proteins in cardiomyocytes from chronic stressed rat. Proteomics. 2004;4:3167-3176.
118. Lescuyer P, Strub JM, Luche S, Diemer H, Martinez P, van Dorsselaer A, Lunardi J, Rabilloud T. Progress in the definition of a reference human mitochondrial proteome. Proteomics. 2003;3:157-167.
119. Pflieger D, Le Caer JP, Lemaire C, Bernard BA, Dujardin G, Rossier J. Systematic identification of mitochondrial proteins by LC-MS/MS. Anal Chem. 2002;74:2400-2406.
120. Hanson BJ, Schulenberg B, Patton WF, Capaldi RA. A novel subfractionation approach for mitochondrial proteins: a three-dimensional mitochondrial proteome map. Electrophoresis. 2001;22:950-959.
121. Carroll J, Fearnley IM, Shannon RJ, Hirst J, Walker JE. Analysis of the subunit composition of complex I from bovine heart mitochondria. Mol Cell Proteomics. 2003;2:117-126.
122. Schagger H, von Jagow G. Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form. Anal Biochem. 1991;199:223-231.
123. Brookes PS, Pinner A, Ramachandran A, Coward L, Barnes S, Kim H, Darley-Usmar VM. High throughput two-dimensional blue-native electrophoresis: a tool for functional proteomics of mitochondria and signaling complexes. Proteomics. 2002;2:969-977.
124. Kruft V, Eubel H, Jansch L, Werhahn W, Braun HP. Proteomic approach to identify novel mitochondrial proteins in Arabidopsis. Plant Physiol. 2001;127:1694-1710.
125. Devreese B, Vanrobaeys F, Smet J, Van Beeumen J, Van Coster R. Mass spectrometric identification of mitochondrial oxidative phosphorylation subunits separated by two-dimensional blue-native polyacrylamide gel electrophoresis. Electrophoresis. 2002;23:2525-2533.
126. Macfarlane DE. Two dimensional benzyldimethyl-n-hexadecylammonium chloride - sodium dodecyl sulfate preparative polyacrylamide gel electrophoresis: a high capacity high resolution technique for the purification of proteins from complex mixtures. Anal Biochem. 1989;176:457-463.
127. Hartinger J, Stenius K, Hogemann D, Jahn R. 16-BAC/SDS-PAGE: a two-dimensional gel electrophoresis system suitable for the separation of integral membrane proteins. Anal Biochem. 1996;240:126-133.
128. Navarre C, Degand H, Bennett KL, Crawford JS, Mortz E, Boutry M. Subproteomics: identification of plasma membrane proteins from the yeast Saccharomyces cerevisiae. Proteomics. 2002;2:1706-1714.
129. Rais I, Karas M, Schagger H. Two-dimensional electrophoresis for the isolation of integral membrane proteins and mass spectrometric identification. Proteomics. 2004;4:2567-2571.
130. Patel VB, Corbett JM, Dunn MJ, Winrow VR, Portmann B, Richardson PJ, Preedy VR. Protein profiling in cardiac tissue in response to the chronic effects of alcohol. Electrophoresis. 1997;18:2788-2794.
131. Patel VB, Sandhu G, Corbett JM, Dunn MJ, Rodrigues LM, Griffiths JR, Wassif W, Sherwood RA, Richardson PJ, Preedy VR. A comparative investigation into the effect of chronic alcohol feeding on the myocardium of normotensive and hypertensive rats: an electrophoretic and biochemical study. Electrophoresis. 2000;21:2454-2462.
132. Toraason M, Moorman W, Mathias PI, Fultz C, Witzmann F. Two-dimensional electrophoretic analysis of myocardial proteins from lead-exposed rabbits. Electrophoresis. 1997;18:2978-2982.
133. Faber MJ, Dalinghaus M, Lankhuizen IM, Bezstarost K, Dekkers DHW, Duncker DJ, Helbing WA, Lamers JMJ. Proteomic changes in the pressure overloaded right ventricle after 6 weeks in young rats: correlations with the degree of hypertrophy. Proteomics. 2005;5:2519-2530.
134. White MY, Cordwell SJ, McCarron HCK, Prasan AM, Craft G, Hambly BD, Jeremy RW. Proteomics of ischemia/reperfusion injury in rabbit myocardium reveals alterations to proteins of essential functional systems. Proteomics. 2005;5:1395-1410.
135. Heinke MY, Wheeler CH, Chang D, Einstein R, Drake-Holland A, Dunn MJ, dos Remedios CG. Protein changes observed in pacing-induced heart failure using two-dimensional electrophoresis. Electrophoresis. 1998;19:2021-2030.
136. Heinke MY, Wheeler CH, Yan JX, Amin V, Chang D, Einstein R, Dunn MJ, dos Remedios CG. Changes in myocardial protein expression in pacing-induced canine heart failure. Electrophoresis. 1999;20:2086-2093.
137. Weekes J, Wheeler CH, Yan JX, Weil J, Eschenhagen T, Scholtysik G, Dunn MJ. Bovine dilated cardiomyopathy: proteomic analysis of an animal model of human dilated cardiomyopathy. Electrophoresis. 1999;20:898-906.
138. Wilkins MR, Gasteiger E, Wheeler CH, Lindskog I, Sanchez JC, Bairoch A, Appel RD, Dunn MJ, Hochstrasser DF. Multiple parameter cross-species protein identification using MultiIdent - a worldwide web accessible tool. Electrophoresis. 1998;19:3199-3206.
139. Field ML, Clark JF. Inappropriate ubiquitin conjugation: a proposed mechanism contributing to heart failure. Cardiovasc Res. 1997;33:8-12.
140. Weekes J, Morrison K, Mullen A, Wait R, Barton P, Dunn MJ. Hyperubiquitination of proteins in dilated cardiomyopathy. Proteomics. 2003;3:208-216.
141. He C, Muller U, Werdan K. Regulation of protein biosynthesis in neonatal rat cardiomyocytes by adrenoceptor-stimulation: investigations with high resolution two-dimensional polyacrylamide gel electrophoresis. Electrophoresis. 1992;13:755-756.
142. He C, Muller U, Oberthur W, Werdan K. Application of high resolution two-dimensional polyacrylamide gel electrophoresis of polypeptides from cultured neonatal rat cardiomyocytes: regulation of protein synthesis by catecholamines. Electrophoresis. 1992;13:748-754.
143. Arnott D, O'Connell KL, King KL, Stults JT. An integrated approach to proteome analysis: identification of proteins associated with cardiac hypertrophy. Anal Biochem. 1998;258:1-18.
144. Macri J, McGee B, Thomas JN, Du P, Stevenson TI, Kilby GW, Rapundalo ST. Cardiac sarcoplasmic reticulum and sarcolemmal proteins separated by two-dimensional electrophoresis: surfactant effects on membrane solubilization. Electrophoresis. 2000;21:1685-1693.
145. Arrell DK, Neverova I, Fraser H, Marban E, Van Eyk JE. Proteomic analysis of pharmacologically preconditioned cardiomyocytes reveals novel phosphorylation of myosin light chain 1. Circ Res. 2001;89:480-487.
146. van der Velden J, Papp Z, Zaremba R, Boontje NM, de Jong JW, Owen VJ, Burton PB, Goldmann P, Jaquet K, Stienen GJ. Increased Ca2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins. Cardiovasc Res. 2003;57:37-47.
147. Latif N, Baker CS, Dunn MJ, Rose ML, Brady P, Yacoub MH. Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and western blotting. J Am Coll Cardiol. 1993;22:1378-1384.
148. Pohlner K, Portig I, Pankuweit S, Lottspeich F, Maisch B. Identification of mitochondrial antigens recognized by antibodies in sera of patients with idiopathic dilated cardiomyopathy by two-dimensional gel electrophoresis and protein sequencing. Am J Cardiol. 1997;80:1040-1045.
149. Pankuweit S, Portig I, Lottspeich F, Maisch B. Autoantibodies in sera of patients with myocarditis: characterization of the corresponding proteins by isoelectric focusing and N-terminal sequence analysis. J Mol Cell Cardiol. 1997;29:77-84.
150. Latif N, Rose ML, Yacoub MH, Dunn MJ. Association of pretransplantation antiheart antibodies with clinical course after heart transplantation. J Heart Lung Transplant. 1995;14:119-126.
151. Wheeler CH, Collins A, Dunn MJ, Crisp SJ, Yacoub MH, Rose ML. Characterization of endothelial antigens associated with transplant-associated coronary artery disease. J Heart Lung Transplant. 1995;14:S188-S197.
152. deSouza AJ, Wait R, Mitchell AG, Banner NR, Dunn MJ, Rose ML. Heat shock protein 27 is associated with freedom from graft vaculopathy after human cardiac transplantation. Circ Res. 2005;97:192-198.
153. Borozdenkova S, Westbrook JA, Patel V, Wait R, Bolad I, Burke MM, Bell AD, Banner NR, Dunn MJ, Rose ML. Use of proteomics to discover novel markers of cardiac allograft rejection. J Proteome Res. 2004;3:282-288.